Filing Details

Accession Number:
0001209191-12-021984
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-04 13:00:00
Reporting Period:
2012-04-02
Filing Date:
2012-04-04
Accepted Time:
2012-04-04 17:02:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373040 Des Walsh 800 W. Olympic Boulevard, #406
Los Angeles CA 90015
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-02 50,000 $7.50 175,525 No 4 M Direct
Common Stock Disposition 2012-04-02 50,000 $69.46 125,525 No 4 S Direct
Common Stock Acquisiton 2012-04-02 44,390 $6.82 169,915 No 4 M Direct
Common Stock Disposition 2012-04-02 23,025 $70.11 146,890 No 4 D Direct
Common Stock Disposition 2012-04-03 21,365 $69.40 125,525 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2012-04-02 50,000 $0.00 50,000 $7.50
Common Stock Stock Appreciation Rights Disposition 2012-04-02 44,390 $0.00 44,390 $6.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-04-27 No 4 M Direct
0 2019-02-27 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2011.
  2. This transaction was executed in multiple trades at prices ranging from $69.11 to $69.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. These options were fully vested as of June 30, 2005.
  4. These stock appreciation rights were fully vested as of February 27, 2012.